Melanoma presents challenges for timely and accurate diagnosis. Expert panels have issued risk-based screening guidelines, with recommended screening by visual inspection. To assess how recent technology can impact the risk/benefit considerations for melanoma screening, we comprehensively reviewed non-invasive visual-based technologies.
View Article and Find Full Text PDFBackground: Functional status assessment may help estimate which patients ≥85 years of age will benefit from surgical treatment for keratinocyte carcinoma (KC), but predictive value for short-term survival in this population has not been determined.
Objective: We sought to assess the predictive value of functional status for short-term survival in patients ≥85 years of age who have KC.
Methods: This was a retrospective cohort review of 238 patients ≥85 years of age who presented for the management of KC between 2010 and 2015.